4.4 Prostate gland Flashcards
BPH - CFs, associations
50-75% males >60 y/o
More common in Blacks, HTN, DM
Involves transitional zone - glandular tissue surrounding prostatic urethra, at proximal end veru montanum
Imaging findings BPH
IVP: ‘J-hook’ distal ureters (due to elevated interureteric ridge)
± ureteric dilatation / tortuosity if long-standing
bladder trabeculation / diverticula with prominent prostatic impression
US: Adenomatous nodules may appear as hypo-/hyperechoic regions; Can usually differentiate central and transitional zones
MR: Hyperplastic nodules high signal on T2W, can be low or high on T1W; Stromal proliferation gives low signal on T1W and T2W
Imaging features of prostatitis
Low signal on T2W in peripheral zone, no focal mass or capsular irregularity
If chronic, can appear similar to cancer
Gleason Grading of Prostate Cancer
Grade 1: well differentiated, Grade 5: Poorly differentiated (4 & 5 have potential for lymphatic spread)
Overall score is sum of two predominant histological patterns summated to give overall score (2-4 well differentiated, 5-7 moderately differentiated, 8-10 poorly differentiated)
Prostate cancer - location, stage and US imaging appearances
85% located in peripheral zone
Tumour grading and size predict prognosis
Cancer elevates PSA x10 more than BPH
US: Usually oval hypoechoic lesion in peripheral zone (but only 10% of these are cancer)
Prostate cancer MRI appearances
Axial T1W & T2W with sagittal T2W detects periprostatic extent
Tumours in peripheral zone show relatively low T2W signal (but non-specific)
T1W detects haemorrhage
Cancer shows early rapid enhancement then early washout
Criteria for extracapsular spread: neurovascular asymmetry, angulated gland contour, obliteration of retroprostatic angle
Spectroscopy - cancers show low citrate and high choline (thus elevated choline/citrate ratio >2 SD above average for peripheral zone)
Mucinous adenocarcinoma and small infiltrating cancers hardest to detect
Prostate Cancer Staging
Stage - A: Occult, B: Confined to capsule (treated with radical surgery), C: Extracapsular spread, D: Distant metastasis
T stage
1: only on histology or DRE
2a: Less than half of one side; 2b: >half of one side
2c: both sides of prostate
3a: extracapsular extension without seminal vesicle invasion; 3b: seminal vesicle invasion
4: spread to sphincter / rectum / pelvic wall
M - 1: regional nodes; 1a: distant LNs; 1b: osseous; 1c: visceral disease
Prostate cancer nodal and metastatic spread - LNs, osseous, visceral and PSA
LNs: Obturator, Internal and external iliac LN’s; 80% with nodal disease develop bone metastases at 5 years
Osseous: 85% osteoblastic, 5% lytic, 10% mixed; pelvis > lumbar > femur > thoracic;
PSA > 58 suggests bone metastases; PSA less than 20 and no bone pain - 0.2% risk bone metastases
Intrathoracic: 6% patients at first diagnosis; 25% patients with stage D have lung or pleural disease; Lymphangitis carcinomatosis more common than lung nodules